![Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram](https://www.researchgate.net/publication/277412952/figure/fig2/AS:391983605534721@1470467582705/Patient-no-7-with-a-rising-PSA-level-to-13-ng-ml-In-the-past-the-patient-had-left.png)
Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram
![PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association](https://www.auanet.org/images/Education/clinical-guidance/Prostate-Specific-Antigen-Figure-2.jpg)
PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml | PLOS ONE
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania](https://www.mdpi.com/jcm/jcm-09-03826/article_deploy/html/images/jcm-09-03826-g001.png)
JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
![A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology](https://www.auajournals.org/cms/asset/3e9b0bb9-dff8-4dc9-a376-6265bd3e4176/abs-fig.jpg)
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology
![Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml | BMC Urology | Full Text Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-020-00717-z/MediaObjects/12894_2020_717_Fig3_HTML.png)
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml | BMC Urology | Full Text
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
![SciELO - Brazil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and SciELO - Brazil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and](https://minio.scielo.br/documentstore/1677-6119/jVxLkMSNXSmzhDyDd34Kgvd/97855423eadaa475aa2bff26d9ae03085ce47923.jpg)
SciELO - Brazil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t3.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - ScienceDirect Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429598006402-gr1.gif)
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - ScienceDirect
![Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep22050/MediaObjects/41598_2016_Article_BFsrep22050_Fig1_HTML.jpg)